This site is intended for health professionals only

Covid-19 Primary Care Resources


Management of Covid-19 anosmia



A guideline from the British Rhinological Society

This information is sourced from ENT UK:

Key points for management of anosmia/loss of smell (LOS):

  • Covid status should be established through history/PCR/serology in patients with LOS if possible
  • Olfactory training and support Olfactory training is recommended to patients with LOS more than 2 weeks; it is recommended that patients are directed to AbScent and Fifth Sense for further support

Isolated loss of smell (LOS)

Patients with Covid infection

  • LOS less than three months: GP management (see above)
  • LOS more than three months: ENT referral
  • Oral Corticosteroids/omega 3 supplements are treatment options if the patient has completely recovered from all other symptoms of Covid-19

Patients with no Covid infection

LOS more than 4-6 weeks: ENT referral

Loss of smell (LOS) associated with nasal symptoms (blockage/congestion)

  • Intranasal corticosteroid sprays are recommended in patients with LOS more than 2 weeks associated with nasal symptoms
  • Intranasal corticosteroid drops or rinses are optional to recommend in patients with LOS more than 2 weeks associated with nasal symptoms
  • All patients with LOS more than 4-6 weeks associated with nasal symptoms should be referred to ENT

Loss of smell (LOS) associated with neurological symptoms (including persistent gustatory dysfunction)

  • All patients with LOS more than 6 weeks with additional neurological symptoms should have an MRI scan of brain regardless of Covid-19 status

Sources

BRS COVID anosmia guidelines – recommendations

Published: 19/05/2020